期刊文献+

MMP1 mRNA在口腔鳞癌与正常黏膜中的表达及临床意义 被引量:7

Expression of MMP1 mRNA in oral squamous cell carcinoma and paired normal tissues
下载PDF
导出
摘要 目的探讨基质金属蛋白酶1(MMP1)mRNA在口腔鳞状细胞癌(OSCC)及配对正常口腔黏膜组织中的表达及临床意义。方法用RT-PCR方法检测30例OSCC患者肿瘤组织及其配对的正常口腔粘膜中MMP1mRNA的表达;所得数据采用t-test检验方法进行统计学处理。结果RT-PCR检测结果表明,MMP1mRNA在OSCC和配对正常粘膜的表达水平分别为4.06±0.52和1.24±0.17,上调3.26倍(P<0.0001)。在30例OSCC标本中,MMP1mRNA表达在病理Ⅱ/Ⅲ级OSCC中的表达(4.31±0.68)高于Ⅰ级OSCC的表达(3.87±0.57)(P>0.05);在临床Ⅲ/Ⅳ期OSCC患者标本中的表达水平(4.18±0.67)高于Ⅰ/Ⅱ期OSCC的表达水平(3.65±0.53)(P>0.05);在颈淋巴结阳性OSCC患者的表达水平(4.32±0.71)高于颈淋巴结阴性OSCC患者的表达水平(3.91±0.51)(P>0.05)。结论MMP1可能在OSCC的侵袭过程中起重要作用,可能是OSCC诊断、治疗及预后判断的一个基因靶标;MMP1在OSCC分类诊断中有应用价值。 Objective To investigate the mRNA expression of matrix metalloproteinase 1 (MMP1) gene in oral squamous cell carcinoma (OSCC) and the paired normal tissues. Methods The differential expression of MMP1 mRNA between 30 OSCC and paired normal tissues were detected with reverse transcription-PCR (RT-PCR). Results The relative expression level of MMP1 mRNA in the OSCC tissues showed a 3.26-fold increase in comparison with that in the paired normal tissues (4.06±0.52 vs 1.24±0.17, P〈0.0001). In the 30 OSCC tissues, the relative expression level of MMP1 mRNA was higher in histological grade II/III tissues (4.31±0.68) than in grade I (3.87±0.57) tissues, higher in OSCC in advanced stages (III/IV) than in tumors in early stages (I/II) (4.18±0.67 vs 3.65±0.53), and also higher in OSCC with cervical lymph node invasion than in those without cervical lymph node invasion (4.32±0.71 vs 3.91±0.51), but these differences were not statistically significant (P〉0.05). Conclusion MMP1 gene may play a role in local invasion of OSCC, and can serve as a potential biomarker molecule for diagnosis, treatment and prognostic evaluation of OSCC, with also clinical value for OSCC classification.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2008年第8期1362-1364,共3页 Journal of Southern Medical University
基金 国家自然科学基金重点项目(30330580) 上海市科学技术委员会项目(036505013 034107002)
关键词 口腔 鳞状细胞癌 基质金属蛋白酶1 RT-PCR oral squamous cell carcinoma matrix metalloproteinase 1 reverse transcription-polymerase chain reaction
  • 相关文献

参考文献15

  • 1Thomas GT, Lewis MP, Speight PM. Matrix metalloproteinases and oral cancer[J]. Oral Oncol, 1999, 35: 227-33.
  • 2Ziober BL, Turner MA, Palefsky JM, et al. Type Ⅰ collagen degradation by invasive oral squamous cell carcinoma[J]. Oral Oncol, 2000, 36(4): 365-72.
  • 3Kerkela E, Saarialho-Kere U. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer[J]. Exp Dermatol, 2003, 12(2): 109-25.
  • 4Murray GI, Duncan ME, O'Neil P, et al. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer [J]. Pathology, 1998, 185(3): 256-61.
  • 5Hilska M, Roberts P J, Collan YU, et al. Prognostic significance of matrix metaUoproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer [J].Int J Cancer, 2007, 121(4): 714-23.
  • 6Moser PL, Kieback DG, Hefler L, et al. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancer [J]. Anticancer Res, 1999, 19(5C): 4391-3.
  • 7Choi YD, Cho Nil, Ahn HS, et al. Matrix metalloproteinase expression in the recurrence of superficial low grade bladder transitional cell careinoma[ J ]. J Urol, 2007, 177(3): 1174-8.
  • 8Baker EA, Leaper D J, Hayter JP, et al. The matrix metalloproteinase system in oral squamous cell carcinoma [J]. Br J Oral Maxillofac Surg, 2006, 44(6): 482-6.
  • 9Jordan RC, Macabeo-Ong M, Shiboski CH, et al. Overexpression of matrix metalloproteinase-1 and-9 mRNA is associated with progression of oral dysplasia to cancer[J]. Clin Cancer Res, 2004, 10(19): 6460-5.
  • 10Shyu KG, Hsu FL, Wang MJ, et al. Hypoxia-inducible factor lalpha regulates lung adenocarcinoma cell invasion [J]. Exp Cell Res, 2007, 313(6): 1181-91.

二级参考文献12

  • 1于世凤 汪说之.口腔组织病理学(第5版)[M].北京:人民卫生出版社,2004.265-268.
  • 2Sidenius N, Blasi F. The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy. Cancer Metastasis Rev, 2003, 22 (2-3) :205
  • 3La Rocca G, Pucci-Minafra I, Marrazzo A,et al. Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. Br J Cancer, 2004, 90(7) : 1414
  • 4Yoshizaki T, Sato H, Furukawa M. Recent advances in the regulation of matrix metalloproteinase 2 activation. From basic research to clinical implication (Review). Oncol Rep, 2002,9(3) :607
  • 5Yorioka CW, Coletta RD, Alves F, et al. Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients. Int J Oncol,2002, 20(1) :189
  • 6Tsai CH, Hsieh YS, Yang SF, et al. Matrix metalloproteinase 2 and matrix metalloproteinase 9 expression in human oral squamous cell carcinoma and the effect of protein kinase C inhibitors: Preliminary observations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2003, 95(6) :710
  • 7Tanaka Y, Kobayashi H, Suzuki M, et al. Transforming growth factor-betal-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells. J Biol Chem,2004, 279(10): 8567
  • 8Nelson AR, Fingleton B, Rothenberg ML,et al. Matrix metalloproteinases: Biologic activity and clinical implications. J Clin Oncol, 2000,18(5) :1135
  • 9Schmitt M, Wilhelm O, Janicke F, et al. Urokinase-type plasminogen activator (uPA) and its receptor (CD87) :A new target in tumor invasion and metastasis. J Obstet Gynaecol,1995, 21(2) :151
  • 10Sobin LH. TNM classification of malignanttumors/UICC. 6th ed. New York: Wily-Liss, 2002. 118 -126

共引文献10

同被引文献39

引证文献7

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部